Category: VEITH 2022

Viz.ai announces positive new data from large aortic dissection AI real-world study at VEITHsymposium 2022

Viz.ai recently announced new data from a large aortic dissection artificial intelligence (AI) real-world study that supports the use of its AI technology for the detection of suspected aortic dissection. Data from the new study, which were presented this week at VEITHsymposium 2022 (15–19 November, New York, USA), validate the company’s industry-leading dissection detection algorithm, part […]

The post Viz.ai announces positive new data from large aortic dissection AI real-world study at VEITHsymposium 2022 appeared first on Vascular News.

SWING trial 12-month data: Novel sirolimus DCB shows “great promise” in “challenging” CLTI population

The Sundance (Surmodics) sirolimus drug-coated balloon (DCB) has an “excellent” safety profile in a “challenging, real-world, predominantly CLTI [chronic limb-threatening ischaemia] population,” and has a primary patency rate of 80% at 12 months in a per-protocol analysis population. Ramon Varcoe (Prince of Wales Hospital, Sydney, Australia) presented these findings from the SWING first-in-human study at […]

The post SWING trial 12-month data: Novel sirolimus DCB shows “great promise” in “challenging” CLTI population appeared first on Vascular News.